Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Precision Therapeutics Inc (AIPT)

Precision Therapeutics Inc (AIPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
BioLife Solutions and SAVSU Technologies to be Awarded Second Patent for Next Generation Cold Chain Technologies Designed for Cell and Gene Therapies

BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media, and SAVSU Technologies,...

BLFS : 15.21 (+1.74%)
Precision Therapeutics Gains Extension for Nasdaq Compliance

Precision Therapeutics Inc. (Nasdaq: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that Nasdaq...

AIPT : 0.64 (+6.67%)
Precision Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update

Precision Therapeutics Inc. (Nasdaq: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, today announced financial results...

AIPT : 0.64 (+6.67%)
Precision Therapeutics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 15, 2019 / Precision Therapeutics, Inc. (NASDAQ: ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 15, 2019 at 4:30 PM Eastern...

AIPT : 0.64 (+6.67%)
Precision Therapeutics to Report First Quarter 2019 Financial Results and Provide Company Update on Wednesday, May 15, 2019

Conference Call to be held May 15, 2019, at 4:30pm Eastern Time

AIPT : 0.64 (+6.67%)
Precision Therapeutics' Subsidiary Helomics and National Alopecia Areata Foundation Sign Services Agreement to Provide Next-Generation Patient Registry for Alopecia Areata Research

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company") today announced a services agreement between its wholly owned subsidiary, Helomics and the National Alopecia Areata Foundation...

AIPT : 0.64 (+6.67%)
Precision Therapeutics' Subsidiary TumorGenesis and its Partner 48Hour Discovery Inc. Receive Alberta Innovates Product Demonstration Program Grant to Support Development of Novel Cancer Treatments

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company") today announced that its wholly owned subsidiary, TumorGenesis, is participating with 48Hour Discovery (48HD), a Canadian partner,...

AIPT : 0.64 (+6.67%)
Precision Therapeutics' Subsidiary, Helomics(R) Corporation, and SpeciCare, Inc. to Study Innovative Personalized Medicine Opportunities for Cancer Patients

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company") today announced that its wholly-owned subsidiary, Helomics(R) Corporation (Helomics), which provides personalized medicine solutions...

AIPT : 0.64 (+6.67%)
Uptick Newswire Hosts Precision Therapeutics Inc. on The Stock Day Podcast to Discuss Massive Revenue Increases

PHOENIX, AZ / ACCESSWIRE / April 11, 2019 / Uptick Newswire Stock Day Podcast welcomed Precision Therapeutics Inc. (NASDAQ: ) ("the Company"), a company with business lines that include applying artificial...

AIPT : 0.64 (+6.67%)
SKLN : 1.21 (-11.03%)
Precision Therapeutics' Subsidiary Helomics to Collaborate with Viome to Explore the Impact of the Gut Microbiome on Ovarian Cancer

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company") today announced a collaboration between its wholly owned subsidiary, Helomics, and Viome, a new kind of healthcare company transforming...

AIPT : 0.64 (+6.67%)
Precision Therapeutics Announces Completion of Merger with Helomics Holding Corporation

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision Therapeutics" or "the Company"), today announced the completion of its merger with Helomics Holding Corporation ("Helomics"), which has become the...

AIPT : 0.64 (+6.67%)
Precision Therapeutics Reports Year End 2018 Financial Results and Provides Corporate Update

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to Women's Oncology, announced today financial results for the quarter and...

AIPT : 0.64 (+6.67%)
Dawson James Securities Announces the Closing of Public Offering for Precision Therapeutics Inc.

Dawson James Securities Inc. in conjunction with Precision Therapeutics Inc. (NASDAQ: AIPT) announced the closing on March 28 of its public offering of 1,478,750 units at $.80 per unit. Each unit consisted...

AIPT : 0.64 (+6.67%)
Precision Therapeutics Inc. Announces Pricing of Public Offering of Up to $1.2 Million of Units

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company") today announced the pricing of its previously announced public offering of its common stock and warrants to purchase common stock,...

AIPT : 0.64 (+6.67%)
Precision Therapeutics Inc. Announces Proposed Public Offering of Securities

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company") today announced a proposed public offering of its common stock and warrants to purchase common stock. The offering is subject to...

AIPT : 0.64 (+6.67%)
Precision Therapeutics Announces Results of Special Meeting of Stockholders

Precision Therapeutics Inc. (Nasdaq: AIPT) (the "Company") announced today that at a special meeting of stockholders held on March 22, 2019, the Company's stockholders approved the Amended and Restated...

AIPT : 0.64 (+6.67%)
Precision Therapeutics to Report Fiscal Year 2018 Financial Results and Provide Company Update on Monday, April 1, 2019

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company") today announces that it will report Fiscal Year 2018 financial results for the period ended December 31, 2018, after the market...

AIPT : 0.64 (+6.67%)
Viome and Helomics Partner to Identify Personalized Treatment for Ovarian Cancer Patients

Viome, a company transforming health through personalized nutrition based on individual biology, today announces it will collaborate with precision health leader, Helomics, to study the link between the...

AIPT : 0.64 (+6.67%)
Precision Therapeutics Extends Exchange Offer for Helomics Notes and Warrants

Precision Therapeutics Inc. (AIPT) ("Precision" or "the Company") today announced the extension of its previously announced offer (the "Exchange Offer") to holders of certain promissory notes (the "Helomics...

AIPT : 0.64 (+6.67%)
Precision Therapeutics' Skyline Medical Division Captures Market Share in Saudi Arabia Via New Orders While Disposable Sales Show Significant Year-Over-Year Increase

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company") today announced that its Skyline Medical division, has entered the African continent, further expanding the company's global presence...

SKLN : 1.21 (-11.03%)
AIPT : 0.64 (+6.67%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI -1.54 , AIZ +0.24 , SBAC -1.35 , SO -0.28 , WELL -0.42
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar